glycan
form
highli
variabl
constitu
mucos
surfac
profoundli
affect
suscept
infect
diseas
divers
import
surfac
glycan
seen
individu
lack
function
copi
fucosyltransferas
gene
repres
around
onefifth
popul
individu
alter
suscept
mani
bacteri
viral
infect
diseas
mediat
hostpathogen
interact
mucos
glycan
ad
poorli
understood
highlight
specif
exampl
import
mechan
host
glycan
influenc
infect
dynam
includ
act
pathogen
receptor
receptordecoy
promot
microbi
stabil
alter
physic
characterist
mucu
act
immunolog
marker
argu
effect
glycan
infect
dynam
profound
implic
mani
aspect
healthcar
polici
includ
clinic
manag
outbreak
control
vaccin
polici
mucos
infect
account
onetenth
death
global
major
sourc
morbid
predomin
infect
respiratori
tract
gastrointestin
tract
genitourinari
tract
site
expos
extern
sourc
encount
microbi
pathogen
unavoid
howev
likelihood
interact
result
infect
vari
substanti
individu
abil
predict
outcom
exposur
remain
central
challeng
modern
medicin
extent
mucos
surfac
influenc
risk
infect
complex
remain
poorli
understood
often
mucosa
oversimplifi
mere
physic
barrier
howev
molecular
composit
consist
intric
glycan
structur
see
glossari
secret
protein
lipid
provid
mani
addit
immunolog
function
larg
divers
glycan
display
mucos
surfac
determin
inherit
variat
transcript
regul
within
epitheli
cell
importantli
interindividu
variat
type
glycan
present
mucos
surfac
major
contributor
differ
suscept
varieti
infect
inde
contribut
mucos
glycan
infect
suscept
gain
much
recent
interest
owe
studi
provid
mechanist
insight
function
mucos
constitu
decor
glycan
form
process
mediat
divers
famili
glycosyltransferas
enzym
mostli
act
templateindepend
manner
encod
fucosyltransferas
express
mucos
tissu
trend
mucos
surfac
form
major
interfac
us
extern
environ
surfac
decor
complex
sugar
moieti
profoundli
affect
function
individu
variat
mucos
sugar
contribut
overal
infect
diseas
suscept
within
popul
recent
mechanist
studi
involv
mous
model
reveal
gene
mediat
hostbacteri
interact
via
effect
mucos
surfac
need
characteris
role
mucos
sugar
bacteri
viral
infect
dynam
describ
sever
mechan
highlight
import
mucos
sugar
host
defenc
contribut
diseas
suscept
variat
glycan
within
popul
may
play
crucial
yet
underappreci
role
viralinfect
suscept
potenti
inform
clinic
manag
glossari
gene
encod
fucosyltransferas
express
epitheli
cell
multipl
mucos
tissu
enzym
catalys
addit
lfucos
termin
galactos
glycan
confirm
fucosyl
glycan
term
h
antigen
glycan
polym
coval
link
sugar
monom
glycosyltransferas
enzym
catalys
transfer
sugar
monom
donor
acceptor
substrat
molecul
form
glycan
divers
rang
glycosyltransferas
exist
particular
specif
sugar
monom
glycosid
linkag
microbiota
commens
symbiot
pathogen
microorgan
share
defin
nich
natur
antibodi
nab
immunoglobulin
produc
independ
cell
select
nab
gener
weaker
affin
lower
specif
compar
celldepend
immunoglobulin
nonsecretor
individu
two
lossoffunct
mutat
gene
therefor
fail
express
fucosyl
glycan
mucos
secret
cellsurfac
glycoprotein
glycolipid
multipl
epitheli
cell
type
facilit
attach
lfucos
monosaccharid
specif
olink
glycan
chain
produc
fucosyl
glycan
result
fucosyl
glycan
highli
versatil
structur
modifi
form
one
number
clinic
import
glycan
includ
b
histoblood
group
antigen
mucos
surfac
mucos
histoblood
group
analog
found
erythrocyt
although
secret
mucos
surfac
depend
exampl
individu
blood
type
express
atyp
glycan
erythrocyt
express
atyp
glycan
mucos
surfac
function
glycosyl
process
fucosyl
protein
lipid
either
secret
mucos
epithelium
lumen
directli
anchor
apic
cell
surfac
membran
control
natur
variou
fucosyl
glycan
secret
mucos
surfac
term
secretor
gene
although
regul
secret
per
se
fucosyl
glycan
act
import
precursor
rang
mucos
glycan
high
frequenc
nonsens
snp
within
gene
human
perhap
surpris
fact
approxim
onefifth
global
popul
harbour
two
nonfunct
allel
therefor
unabl
express
fucosyl
glycan
mucos
surfac
individu
function
allel
term
secretor
lossoffunct
mutat
term
nonsecretor
interestingli
frequenc
nonsecretor
vari
substanti
ethnic
rang
snp
found
confer
nonsecretor
phenotyp
howev
widespread
distribut
trait
indic
conserv
select
advantag
nonsecretor
certain
circumst
box
addit
absenc
fucosyl
glycan
mucos
secret
includ
absenc
histoblood
group
antigen
nonsecretor
also
display
increas
level
sialyl
glycan
mucos
secret
presum
result
reduc
glycosyltransferas
competit
clue
lossoffunct
mutat
carri
high
frequenc
illustr
gener
import
surfac
glycan
infect
suscept
major
differ
rate
bacterialand
viralmedi
diseas
secretor
nonsecretor
tabl
key
tabl
larg
number
studi
report
significantli
higher
rate
viral
infect
secretor
includ
lifethreaten
infect
caus
hiv
influenza
noroviru
time
secretor
appear
reduc
risk
infect
caus
bacteri
pathogen
includ
streptococcu
pneumonia
neisseria
meningitidi
haemophilu
influenza
salmonella
enterica
serovar
typhimurium
dichotomi
suscept
also
extend
chronic
multifactori
diseas
chronic
pancreat
diseas
alter
immun
regul
asthma
type
diabet
psoriasi
import
note
studi
list
tabl
report
signific
associ
secretor
statu
diseas
sampl
size
effect
size
vari
multipl
snp
found
code
region
confer
loss
hinder
function
common
nonsens
snp
caucasian
african
central
asian
popul
g
substitut
base
pair
howev
common
east
asian
popul
substitut
base
pair
snp
occur
similar
frequenc
respect
popul
estim
date
emerg
mutat
least
million
year
ago
mutat
least
year
ago
age
frequenc
mutat
suggest
maintain
gene
pool
balanc
select
secretor
nonsecretor
variant
provid
select
advantag
avail
evid
suggest
differenti
resist
infect
driver
balanc
select
although
identif
caus
infect
agent
specul
howev
phenomenon
observ
outsid
human
popul
infectiondriven
select
glycosyltransferas
variant
report
studi
rabbit
popul
endem
rabbit
haemorrhag
diseas
viru
glycosyltransferas
snp
higher
frequenc
compar
popul
without
endem
viru
diseas
secretor
phenotyp
associ
increas
suscept
viral
infect
respiratori
diseas
sever
decreas
suscept
bacteri
infect
divers
rang
chronic
inflammatori
diseas
b
demonstr
mice
human
epidemiolog
evid
c
abbrevi
cf
cystic
fibrosi
despit
welldescrib
associ
mucos
glycosyltransferas
divers
infect
diseas
understand
mechan
behind
relationship
remain
poor
infect
pathogenesi
complex
process
mucos
glycan
like
influenc
suscept
direct
indirect
mechan
stick
around
pathogen
adher
fucosyl
glycan
influenc
infect
suscept
directli
facilit
pathogen
adher
review
detail
multipl
bacteria
encod
specif
receptor
bind
host
fucosyl
glycan
pathogen
adher
well
characteris
exampl
helicobact
pylori
facilit
baba
adhesin
baba
specif
lewi
b
fucosyl
mucos
glycan
therefor
babaexpress
h
pylori
readili
abl
adher
gastric
mucosa
colon
stomach
secretor
individu
figur
babaencod
h
pylori
subsequ
infect
suscept
someth
except
bacteri
speci
list
tabl
suscept
increas
secretor
due
specif
baba
toward
fucosyl
glycan
two
virus
analog
receptor
noroviru
specif
strain
rotaviru
specif
strain
contain
spike
protein
virus
encod
differ
adhesin
specif
fucosyl
glycan
absenc
glycan
nonsecretor
therefor
confer
high
level
resist
figur
complex
pathogen
adher
pathway
also
characteris
base
glycan
locat
glycosyl
protein
lipid
abund
gastrointestin
tract
either
anchor
cell
surfac
secret
lumen
taken
ingest
therefor
infect
suscept
pathogen
adher
glycan
depend
locat
anchor
glycan
glycan
attach
epithelium
fact
reduc
infect
suscept
act
receptor
decoy
exampl
cell
surfac
mucin
carri
lewisb
glycan
shed
surfac
gastric
epitheli
cell
act
releas
decoy
limit
adhes
babaexpress
h
pylori
cell
surfac
lewisbexpress
molecul
separ
exampl
matern
secretor
statu
affect
glycosyl
glycoprotein
milk
consequ
matern
secretor
reduc
infant
suscept
campylobact
jejuni
diarrhoea
attribut
c
jejuni
bind
fucosyl
milk
glycan
act
receptor
decoy
infant
sequest
pathogen
away
epithelium
figur
exampl
demonstr
dynam
glycanmedi
adher
either
membranebound
lumin
ultim
confer
suscept
resist
infect
complex
addit
influenc
pathogen
adher
shown
also
affect
infect
suscept
indirectli
exampl
murin
studi
shown
presenc
reduc
suscept
typhimurium
enterococcu
faecali
citrobact
rodentium
infect
effect
fucosyl
glycan
commens
gut
microbiota
figur
even
small
chang
microbiota
composit
alter
nutrient
avail
profoundli
affect
abil
bacteri
pathogen
colonis
gut
beyond
colonis
resist
murin
studi
also
shown
fucosyl
glycan
import
endogen
nutrient
commens
microb
facilit
rapid
host
recoveri
follow
period
stress
caus
intestin
infect
inflamm
find
support
silico
analys
microbi
structur
stabil
use
microbiota
data
knockout
mice
contrast
larg
studi
healthi
adult
human
report
differ
faecal
microbiota
composit
secretor
nonsecretor
contradict
previou
posit
associ
smaller
cohort
analys
mucos
microbiota
biopsi
use
intestin
mucos
biopsi
smaller
cohort
studi
greater
host
genotyp
effect
may
expect
may
explain
discrep
differ
microbiota
composit
resili
may
also
explain
numer
diseas
associ
secretor
statu
detail
tabl
mani
condit
includ
asthma
crohn
diseas
celiac
diseas
psoriasi
associ
intestin
microbiota
composit
secretor
statu
influenc
gut
microbiolog
reason
suggest
secretor
statu
may
contribut
microbiotarel
diseas
suscept
among
predispos
individu
discuss
elsewher
howev
given
numer
confound
environment
exposur
human
popul
larg
cohort
studi
detail
metadata
requir
determin
contribut
secretor
statu
complex
multifactori
diseas
physic
barrier
properti
mucu
defin
primari
function
govern
viscos
permeabl
rheolog
mucin
major
protein
make
mucu
layer
compris
glycan
mass
small
variat
molecular
composit
mucin
glycan
therefor
impact
overal
physic
properti
mucu
fucosyl
mucin
constitut
larg
proport
secretor
mucu
interestingli
nonsecretor
display
higher
level
sialyl
mucin
sialic
acid
like
fucos
often
ad
termin
saccharid
differ
properti
fucos
molecular
level
sialyl
termin
glycan
larger
polar
surfac
compar
fucos
higher
electroneg
chang
sialyl
mucin
therefor
propos
increas
mucu
hydrat
electroneg
repuls
compar
fucosyl
mucin
interest
specul
alter
mucu
characterist
nonsecretor
may
contribut
reduc
suscept
viral
infect
major
contributor
mucos
immun
detect
neutralis
pathogen
secret
antibodi
particularli
natur
antibodi
nab
gener
cellindepend
way
broadspectrum
activ
divers
antigen
subset
nab
affin
toward
glycan
recognis
specif
bacteria
also
glycan
found
natur
within
human
popul
exampl
b
histoblood
group
antigen
elicit
strong
nabspecif
immun
respons
noncompat
individu
best
known
primari
caus
blood
transfus
reaction
interest
research
question
whether
b
antigen
decor
viral
particl
affect
viral
transmiss
histoincompat
host
definit
viral
replic
reliant
hostcel
machineri
includ
glycosyl
host
glycosyltransferas
mani
virus
also
util
host
membran
encapsul
sever
studi
demonstr
virus
shed
epitheli
cell
display
b
glycan
also
display
glycan
specif
cell
line
infect
measl
viru
found
produc
viral
particl
coat
specif
blood
group
glycan
depict
figur
studi
perform
vitro
use
transform
cell
line
support
logic
conclus
virus
cell
express
particular
glycosyltransferas
carri
hostglycan
fingerprint
parent
cell
addit
antihisto
blood
group
nab
found
bind
virus
elicit
antibodymedi
inactiv
studi
investig
nabmedi
viral
neutralis
use
analog
glycan
structur
show
support
result
howev
unlik
nonsecretor
develop
nab
specif
secretor
glycan
fucosyl
glycan
exist
nonmucos
site
reliant
secretor
statu
may
howev
affect
viru
abil
evad
host
antibodi
defenc
mediat
display
abo
histoblood
group
antigen
mucos
secret
virus
come
nonsecretor
would
display
blood
group
antigen
henc
would
affect
antihisto
blood
group
nab
infect
model
requir
elucid
contribut
viral
glycosyl
infect
dynam
major
studi
discuss
observ
stratif
glycosyl
statu
reveal
differ
infect
diseas
suscept
inform
underli
mechan
surround
contribut
glycosyltransferas
remain
limit
see
outstand
question
howev
becom
appar
common
snp
gene
clinic
import
predict
capabl
enter
era
wholegenom
sequenc
becom
increasingli
common
research
larg
cohort
studi
individu
level
predict
tool
risk
suscept
grow
data
repositori
provid
opportun
explor
effect
glycosyl
variabl
risk
infect
diseas
suscept
populationlevel
well
individu
level
glycosyl
statu
might
exampl
inform
popul
level
infect
outbreak
identifi
atrisk
individu
vital
effect
control
manag
global
secur
exampl
retrospect
analysi
peopl
expos
sever
acut
respiratori
syndrom
sar
viru
hong
kong
hospit
found
individu
express
b
histoblood
group
glycan
reduc
frequenc
infect
odd
ratio
support
nabantivir
hypothesi
develop
stratif
strategi
base
glycosyl
compat
could
therefor
inform
reduc
infect
spread
individu
level
identif
common
genet
infect
diseas
risk
factor
snp
could
inform
direct
individu
behaviour
minimis
infect
diseas
risk
particularli
link
risk
factor
appar
link
glycan
variat
antibodi
repertoir
individu
glycosyl
statu
may
inform
patient
stratif
clinic
set
predict
vaccin
efficaci
progress
chronic
diseas
major
grow
clinic
concern
global
increas
preval
chronic
diseas
caus
divers
rang
complex
lifestyl
genet
environment
factor
respiratoryand
gastrointestinalassoci
diseas
often
direct
microbi
compon
mani
seemingli
unrel
chronic
diseas
also
associ
interact
microb
includ
type
diabet
asthma
rheumatoid
arthriti
name
secretor
statu
associ
suscept
mani
chronic
diseas
also
progress
sever
relationship
could
inform
stratif
patient
popul
predict
advers
event
exampl
stratif
patient
noncyst
fibrosi
bronchiectasi
secretor
statu
identifi
chronic
airway
infect
lung
function
pulmonari
exacerb
frequenc
higher
secretor
individu
frequenc
allerg
diseas
also
increas
rapidli
particularli
develop
countri
earlylif
antibiot
exposur
dysregul
microbiota
link
allergen
sensitis
matern
secretor
statu
link
infant
microbiota
composit
nonsecretor
suscept
asthma
psoriasi
earlylif
igeassoci
eczema
essenti
better
understand
influenc
glycan
fucosyl
microbiom
contribut
develop
condit
relationship
might
also
present
opportun
novel
therapeut
strategi
exampl
might
breast
milk
supplement
fucos
reduc
allerg
diseas
suscept
atrisk
infant
oral
supplement
fucos
shown
well
toler
shift
intestin
microbiota
healthi
adult
highlight
safeti
efficaci
potenti
prebiot
era
data
repositori
avail
combin
genom
sequenc
data
clinic
metadata
larg
cohort
effect
genet
variat
gene
mediat
mucos
glycosyl
snp
increas
understand
immunolog
popul
level
creat
opportun
implement
effect
precis
medicin
test
glycanmedi
mechan
infect
diseas
suscept
warrant
assess
inclus
clinic
polici
practic
ultim
precis
medicin
requir
integr
decisionmak
model
encompass
extrins
factor
includ
diet
mental
physic
health
microbiom
intrins
factor
human
genet
subsequ
phenotyp
test
populationlevel
variabl
remain
challeng
better
understand
factor
glycan
mediat
diseas
suscept
offer
potenti
significantli
improv
clinic
outcom
person
genom
sequenc
becom
increasingli
common
might
individu
knowledg
infectiondiseas
suscept
reduc
incid
late
diagnosi
